| 产品编号 | 图片 | CAS No. | 名称及描述 | 规格 | 价格 | 分子式 | 快速订购 |
|---|---|---|---|---|---|---|---|
| GC31170-1mg |
|
115044-69-4 |
Calmodulin-Dependent Protein Kinase II 290-309 - Glpbio |
0 | 需询价 | C103H185N31O24S | |
| GC31169-10mg |
|
79243-10-0 |
Somatostatin-28 1-14 - Glpbio |
0 | 需询价 | C61H105N23O21S | |
| GC31169-5mg |
|
79243-10-0 |
Somatostatin-28 1-14 - Glpbio |
0 | 需询价 | C61H105N23O21S | |
| GC31169-1mg |
|
79243-10-0 |
Somatostatin-28 1-14 - Glpbio |
0 | 需询价 | C61H105N23O21S | |
| GC31168-25mg |
|
77614-16-5 |
Dermorphin - Glpbio |
0 | 需询价 | C40H50N8O10 | |
| GC31168-10mg |
|
77614-16-5 |
Dermorphin - Glpbio |
0 | 需询价 | C40H50N8O10 | |
| GC31168-5mg |
|
77614-16-5 |
Dermorphin - Glpbio |
0 | 需询价 | C40H50N8O10 | |
| GC31168-1mg |
|
77614-16-5 |
Dermorphin - Glpbio |
0 | 需询价 | C40H50N8O10 | |
| GC31167-10mg |
|
653573-60-5 |
Sodium Channel inhibitor 2 - Glpbio |
0 | 需询价 | C26H25Cl2N3O | |
| GC31167-5mg |
|
653573-60-5 |
Sodium Channel inhibitor 2 - Glpbio |
0 | 需询价 | C26H25Cl2N3O | |
| GC31167-1mg |
|
653573-60-5 |
Sodium Channel inhibitor 2 - Glpbio |
0 | 需询价 | C26H25Cl2N3O | |
| GC31166-10mg |
|
786701-13-1 |
Emicerfont (GW876008) - Glpbio |
0 | 需询价 | C22H24N6O2 | |
| GC31166-5mg |
|
786701-13-1 |
Emicerfont (GW876008) - Glpbio |
0 | 需询价 | C22H24N6O2 | |
| GC31166-1mg |
|
786701-13-1 |
Emicerfont (GW876008) - Glpbio |
0 | 需询价 | C22H24N6O2 | |
| GC31165-5mg |
|
90880-35-6 |
Neuropeptide Y (29-64), amide, human (Human neuropeptide Y (29-64)) - Glpbio |
0 | 需询价 | C189H285N55O57S | |
| GC31165-1mg |
|
90880-35-6 |
Neuropeptide Y (29-64), amide, human (Human neuropeptide Y (29-64)) - Glpbio |
0 | 需询价 | C189H285N55O57S | |
| GC31162-5mg |
|
1096485-24-3 |
Neuronostatin-13 human - Glpbio |
0 | 需询价 | C64H110N20O16 | |
| GC31162-1mg |
|
1096485-24-3 |
Neuronostatin-13 human - Glpbio |
0 | 需询价 | C64H110N20O16 | |
| GC31161-5mg |
|
303052-45-1 |
Neuropeptide Y(29-64) - Glpbio |
0 | 需询价 | C189H284N54O58S | |
| GC31161-1mg |
|
303052-45-1 |
Neuropeptide Y(29-64) - Glpbio |
0 | 需询价 | C189H284N54O58S | |
小泰
|
010-60710855
|